TABLE 3.
Factors associated with accepting an eHealth tool to manage OHT in BCS (Seintinelles study, 2020).
| Acceptance of an electronic blister connected to an app | |||
|---|---|---|---|
| Univariable logistic regression analysis | OR | 95% CI | p-value |
| Age (years) | 0.96 | 0.95–0.98 | <0.001 |
| Marital Status | |||
| Single | Ref | ||
| Married | 1.43 | 1.00–2.02 | 0.047 |
| Widow | 0.81 | 0.39–1.74 | 0.589 |
| Divorced | 0.98 | 0.61–1.56 | 0.914 |
| Professional Status | |||
| Employed | Ref | ||
| Sick leave | 0.61 | 0.36–1.04 | 0.065 |
| Job hunting | 0.72 | 0.40–1.34 | 0.291 |
| Retired | 0.53 | 0.39–0.71 | <0.001 |
| Self-employed | 0.79 | 0.49–1.31 | 0.816 |
| Other | 1.26 | 0.73–2.29 | 0.427 |
| Medication for other diseases | |||
| Daily | Ref | ||
| Regularly | 0.34 | 0.17–0.67 | 0.002 |
| In case of need | 1.09 | 0.70–1.72 | 0.718 |
| No | 1.27 | 0.99–1.64 | 0.061 |
| Quality of life | |||
| No effect at all | Ref | ||
| Does not affect much | 1.19 | 0.81–1.74 | 0.367 |
| Some affect | 1.47 | 1.01–2.14 | 0.044 |
| Does affect | 1.88 | 1.24–2.88 | 0.003 |
| Does affect severely | 1.27 | 0.74–2.21 | 0.398 |
| Control over breast BC | |||
| No control at all | Ref | Ref | |
| Not very much control | 1.75 | 1.20–2.57 | 0.004 |
| Some control | 1.59 | 1.11–2.27 | 0.011 |
| Control | 1.19 | 0.81–1.75 | 0.365 |
| A lot of control | 1.04 | 0.63–1.71 | 0.879 |
| taking an adjuvant endocrine therapy | |||
| Yes | Ref | ||
| No | 0.77 | 0.60–0.98 | 0.036 |
| Number of medication adherence support devices/specific techniques used | |||
| 1 | Ref | Ref | |
| 2 | 2.09 | 1.36–3.28 | 0.001 |
| >3 | 2.00 | 1.05–4.14 | 0.047 |
| 0 | 0.71 | 0.55–0.92 | 0.008 |
| BCS′ Satisfaction On Physicians Information Given regarding the | |||
| Nature Of The Treatment | Ref | Ref | |
| Very unsatisfying | 1.46 | 0.86–2.45 | 0.157 |
| Unsatisfying | 1.20 | 0.75–1.92 | 0.437 |
| Correct | 1.71 | 1.05–2.78 | 0.029 |
| Satisfying | 1.64 | 0.97–2.76 | 0.065 |
| Expected Benefits Of The Treatment | |||
| Very unsatisfying | Ref | Ref | |
| Unsatisfying | 1.31 | 0.70–2.45 | 0.394 |
| Correct | 1.13 | 0.64–1.96 | 0.676 |
| Satisfying | 1,76 | 0.99–3.07 | 0.050 |
| Very satisfying | 1.64 | 0.90–2.97 | 0.100 |
| Treatment Side-Effects | |||
| Very unsatisfying | Ref | Ref | |
| Unsatisfying | 1.15 | 0.80–1.66 | 0.446 |
| Correct | 1.01 | 0.71–1.45 | 0.938 |
| Satisfying | 1.64 | 1.09–2.46 | 0.007 |
| Very satisfying | 1.26 | 0.78–2.06 | 0.346 |
| Possession of connected devices or health applications | |||
| No, it doesn’t interest me | Ref | Ref | |
| No, but I know someone close to me who uses them and I am interested | 1.37 | 0.87–1.92 | <0.001 |
| No, but I plan to get one within the next 6 months | 0.70 | 0.20–1.23 | 0.008 |
| Yes but I do not use them | 1.40 | 0.89–1.97 | <0.001 |
| Yes I use them for 1 year | 1.35 | 0.82–1.93 | <0.001 |
| Yes I use them already longer than a year | 1.11 | 0.79–1.43 | <0.001 |